Long-range PCR and capture sequencing methods are being applied to determine patient-specific genomic EWSR1-FLI1 breakpoints which are subsequently used to detect tumor DNA shed in the circulation by digital PCR. The gene discussed is FLI1; the disease is neoplasm.